Serum Phosphate and Long-Term Outcome Among Patients With Stable Heart Failure
Authors:
- Katja Heitmair-WietzorrekKHKatja Heitmair-Wietzorrek
- Matthias FrickMFMatthias Frick
- Nikolaus UmlaufNUNikolaus Umlauf
- Hanno UlmerHUHanno Ulmer
- Gerhard PoelzlGPGerhard Poelzl
- 1 January 2013
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 19 (1) , 25-30
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- FGF23 induces left ventricular hypertrophyJournal of Clinical Investigation, 2011
- Relations of Serum Phosphorus Levels to Echocardiographic Left Ventricular Mass and Incidence of Heart Failure in the CommunityEuropean Journal of Heart Failure, 2010
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly populationAtherosclerosis, 2009
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney DiseaseCirculation, 2009
- The emerging role of phosphate in vascular calcificationKidney International, 2009
- Use of Penalized Splines in Extended Cox-Type Additive Hazard Regression to Flexibly Estimate the Effect of Time-varying Serum Uric Acid on Risk of Cancer Incidence: A Prospective, Population-Based Study in 78,850 MenAnnals of Epidemiology, 2009
- Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic heartsThe Journal of Physiology, 2008
- The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKDJournal of the American Society of Nephrology, 2008
- Prevalence of Chronic Kidney Disease in the United StatesJAMA, 2007
- The effect of oral phosphate administration on major indices of skeletal metabolism in normal subjectsJournal of Bone and Mineral Research, 1986